S
ARCT icon

SignatureFD’s Arcturus Therapeutics ARCT Stock Holding History

SignatureFD’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Hold
2,188
– – ﹤0.01% 2483
2026
Q1 		$16.9K Hold
2,188
– – ﹤0.01% 2277
2025
Q4 		$13.4K Hold
2,188
– – ﹤0.01% 2299
2025
Q3 		$40.3K Buy
+2,188
New +$35.1K ﹤0.01% 1752
2025
Q2 		– Sell
-61
Closed -$646 – 3263
2025
Q1 		$646 Buy
61
+41
+205% +$651 ﹤0.01% 3132
2024
Q4 		$339 Sell
20
-53
-73% -$998 ﹤0.01% 3177
2024
Q3 		$1.69K Buy
73
+26
+55% +$556 ﹤0.01% 2876
2024
Q2 		$1.14K Sell
47
-22
-32% -$667 ﹤0.01% 2880
2024
Q1 		$2.33K Hold
69
– – ﹤0.01% 2764
2023
Q4 		$2.18K Buy
69
+11
+19% +$261 ﹤0.01% 2734
2023
Q3 		$1.48K Hold
58
– – ﹤0.01% 2850
2023
Q2 		$1.66K Hold
58
– – ﹤0.01% 2861
2023
Q1 		$1.39K Sell
58
-29
-33% -$520 ﹤0.01% 2908
2022
Q4 		$1.48K Sell
87
-19
-18% -$331 ﹤0.01% 2886
2022
Q3 		$2K Buy
106
+92
+657% +$1.54K ﹤0.01% 2731
2022
Q2 		$0 Sell
14
-184
-93% -$3.61K ﹤0.01% 3097
2022
Q1 		$5K Buy
198
+130
+191% +$3.32K ﹤0.01% 2458
2021
Q4 		$3K Buy
68
+24
+55% +$978 ﹤0.01% 2549
2021
Q3 		$2K Buy
44
+12
+38% +$538 ﹤0.01% 2596
2021
Q2 		$1K Buy
+32
New +$1.08K ﹤0.01% 2673

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

SignatureFD's ARCT Position: Q2 2026 in Review

SignatureFD held its Arcturus Therapeutics (ARCT) position steady in Q2 2026 at 2,188 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2483.

SignatureFD first reported a position in ARCT in Q2 2021 and has held it in 20 quarters since. The position peaked at $40.3K in Q3 2025. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • SignatureFD held 2,188 shares of Arcturus Therapeutics worth $14.7K as of Q2 2026.
  • SignatureFD left its Arcturus Therapeutics share count unchanged in Q2 2026.
  • Arcturus Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2483 holding.
  • SignatureFD first reported a position in Arcturus Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • SignatureFD's Arcturus Therapeutics position peaked at $40.3K in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.